(R)-1-tert-Butyl 3-methyl pyrrolidine-1,3-dicarboxylate
98%
- Product Code: 123661
CAS:
441717-40-4
| Molecular Weight: | 229.27 g./mol | Molecular Formula: | C₁₁H₁₉NO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09954284 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, inert gas |
Product Description:
This compound is primarily utilized in the field of organic synthesis as a chiral building block. It serves as a key intermediate in the production of various pharmaceuticals, particularly those requiring stereochemical precision. Its structure is valuable in the synthesis of complex molecules, such as active pharmaceutical ingredients (APIs) for drugs targeting neurological disorders, cardiovascular diseases, and other therapeutic areas. Additionally, it is employed in asymmetric synthesis to introduce chiral centers into target molecules, enhancing their biological activity and specificity. Its tert-butyl and methyl ester groups provide versatility in protecting and deprotecting strategies during multi-step synthetic processes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿981.00 |
+
-
|
| 0.250 | 10-20 days | ฿1,674.00 |
+
-
|
| 1.000 | 10-20 days | ฿3,042.00 |
+
-
|
(R)-1-tert-Butyl 3-methyl pyrrolidine-1,3-dicarboxylate
This compound is primarily utilized in the field of organic synthesis as a chiral building block. It serves as a key intermediate in the production of various pharmaceuticals, particularly those requiring stereochemical precision. Its structure is valuable in the synthesis of complex molecules, such as active pharmaceutical ingredients (APIs) for drugs targeting neurological disorders, cardiovascular diseases, and other therapeutic areas. Additionally, it is employed in asymmetric synthesis to introduce chiral centers into target molecules, enhancing their biological activity and specificity. Its tert-butyl and methyl ester groups provide versatility in protecting and deprotecting strategies during multi-step synthetic processes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :